ATE404549T1 - Neue pharmakologisch aktive dauerpheromonverbindung zur steuerung von alterung und stress sowie verfahren zu deren isolierung und kennzeichnung - Google Patents

Neue pharmakologisch aktive dauerpheromonverbindung zur steuerung von alterung und stress sowie verfahren zu deren isolierung und kennzeichnung

Info

Publication number
ATE404549T1
ATE404549T1 AT03799417T AT03799417T ATE404549T1 AT E404549 T1 ATE404549 T1 AT E404549T1 AT 03799417 T AT03799417 T AT 03799417T AT 03799417 T AT03799417 T AT 03799417T AT E404549 T1 ATE404549 T1 AT E404549T1
Authority
AT
Austria
Prior art keywords
stress
pheromone compound
pheromone
labeling
isolation
Prior art date
Application number
AT03799417T
Other languages
English (en)
Inventor
Young Ki Paik
Pan Young Jeong
Original Assignee
Young Ki Paik
Kdr Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Young Ki Paik, Kdr Biotech Co Ltd filed Critical Young Ki Paik
Application granted granted Critical
Publication of ATE404549T1 publication Critical patent/ATE404549T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
AT03799417T 2002-11-14 2003-10-07 Neue pharmakologisch aktive dauerpheromonverbindung zur steuerung von alterung und stress sowie verfahren zu deren isolierung und kennzeichnung ATE404549T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020020070591A KR100700884B1 (ko) 2002-11-14 2002-11-14 약학적으로 유용한 노화 및 스트레스 조절용 신규 페로몬 화합물 및 그 분리정제방법

Publications (1)

Publication Number Publication Date
ATE404549T1 true ATE404549T1 (de) 2008-08-15

Family

ID=36147023

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03799417T ATE404549T1 (de) 2002-11-14 2003-10-07 Neue pharmakologisch aktive dauerpheromonverbindung zur steuerung von alterung und stress sowie verfahren zu deren isolierung und kennzeichnung

Country Status (13)

Country Link
US (1) US7119213B2 (de)
EP (1) EP1603894B1 (de)
JP (1) JP2006506420A (de)
KR (1) KR100700884B1 (de)
CN (1) CN1323078C (de)
AT (1) ATE404549T1 (de)
AU (1) AU2003265002A1 (de)
BR (1) BR0315265A (de)
CA (1) CA2462181A1 (de)
DE (1) DE60322969D1 (de)
MX (1) MXPA05005103A (de)
RU (1) RU2303596C2 (de)
WO (1) WO2004043944A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100556335B1 (ko) 2004-02-05 2006-03-03 정만길 6알-(3,6-디데옥시-엘-아라비노-헥소피라노실옥시)헵타노익산, 그 제조방법 및 그를 포함하는 장기휴면 유발효과
EP2741611A4 (de) 2011-08-08 2015-03-04 California Inst Of Techn Kleinmolekülige verbindungen zur bekämpfung von pathogenen nematoden bei pflanzen und insekten
BR112014003008A2 (pt) 2011-08-08 2017-02-21 Boyce Thompson Intitute For Plant Res "compostos e métodos de modificação de comportamento de um nemátodo”
KR101384330B1 (ko) * 2012-01-17 2014-04-14 연세대학교 산학협력단 다우몬을 유효성분으로 함유하는 항염증용 약학적 조성물
US11464810B2 (en) 2016-08-25 2022-10-11 California Institute Of Technology Ascaroside treatment of eosinophilic esophagitis
CA3140784A1 (en) 2019-05-17 2020-11-26 California Institute Of Technology Ascaroside derivatives and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU136131A1 (ru) * 1960-06-18 1960-11-30 В.Д. Крапивин Устройство дл контрол смазки реверсивного пневмодвигател
JP3227030B2 (ja) * 1993-06-10 2001-11-12 日東電工株式会社 生理活性δ−ラクトンの合成方法
ES2198661T3 (es) 1998-01-21 2004-02-01 Fideline Composiciones que contienen feromonas para disminuir el estres, la ansiedad y la agresividad en los cerdos.

Also Published As

Publication number Publication date
WO2004043944A1 (en) 2004-05-27
DE60322969D1 (de) 2008-09-25
KR100700884B1 (ko) 2007-03-29
RU2005118102A (ru) 2006-01-20
RU2303596C2 (ru) 2007-07-27
EP1603894A4 (de) 2006-09-27
JP2006506420A (ja) 2006-02-23
KR20040042338A (ko) 2004-05-20
CA2462181A1 (en) 2004-05-14
AU2003265002A1 (en) 2004-06-03
EP1603894A1 (de) 2005-12-14
CN1692107A (zh) 2005-11-02
MXPA05005103A (es) 2005-09-30
US20050075389A1 (en) 2005-04-07
EP1603894B1 (de) 2008-08-13
US7119213B2 (en) 2006-10-10
BR0315265A (pt) 2005-08-23
CN1323078C (zh) 2007-06-27

Similar Documents

Publication Publication Date Title
Steyn The structures of five diketopiperazines from Aspergillus ustus
IS6607A (is) Aðferð við framleiðslu peptíða með notkun umritunar-/þýðingarkerfa í tilraunaglasi
DK1809663T3 (da) Fremgangsmåde til oprensning af FSH
NZ587511A (en) Purified lymphotoxin-beta-receptor immunoglobulin fusion proteins and methods of their purification
RU2008128485A (ru) Флавоноидное соединение, обладающее противовирусной активностью
ATE404549T1 (de) Neue pharmakologisch aktive dauerpheromonverbindung zur steuerung von alterung und stress sowie verfahren zu deren isolierung und kennzeichnung
RU2009122202A (ru) Чистая форма рапамицина и способ ее выделения и очистки
DK1797021T3 (da) Fremgangsmåder til fraseparering af modafinil
JP3236282B1 (ja) プラバスタチンを精製する方法
KR101590255B1 (ko) 미생물 Bacillus vallismortis BS07M 균주 발효액으로부터 제조된 고리형 다이펩타이드의 제조방법
Yang et al. A facile and highly diastereoselective aziridination of chiral camphor N-enoylpyrazolidinones with N-aminophthalimide
Elaridi et al. A catalytic asymmetric synthesis of 5, 5-dimethylproline
Weir et al. Synthesis of l-2, 3-trans-3, 4-cis-dihydroxyproline building blocks for peptide synthesis
Aberhart et al. Separation by high-performance liquid chromatography of (3R)-and (3S)-β-leucine as diastereomeric derivatives
Wright et al. 4-Amino-1-oxyl-2, 2, 6, 6-tetramethylpiperidine-3-carboxylic acid (β-TOAC), the first spin-labelled, cyclic, chiral β-amino acid resolved in an enantiomerically pure state
Della Sala et al. Towards the biosynthesis of the aromatic products of the Mediterranean mollusc Scaphander lignarius: Isolation and synthesis of analogues of lignarenones
ATE395360T1 (de) Neues verfahren zur aufreinigung von humanem wachstumshormon
Kamimura et al. Oxyoxazolidinone as an auxiliary for heterocyclic synthesis. Enantioselective formation of N-unprotected 2-pyrrolidones from selenocarboxylate and allylamines via radical cyclization
Alexandre et al. An efficient resolution of (±)-p-tolylvinylsulfoxide using (−)-menthol
Wright et al. Synthesis and spectroscopic characterization of enantiopure protected trans-4-amino-1-oxyl-2, 2, 6, 6-tetramethyl piperidine-3-carboxylic acid (trans β-TOAC)
Kiss et al. Synthesis of Alicyclic trans-β-Amino Acids from cis-β-Hydroxycycloalkanecarboxylates
DE60034950D1 (de) Trennung durch distillative extraktion
Wang et al. Efficient synthesis of (S)-(−)-and (R)-(+)-enantiomers of 15-deoxyspergualin (15-DSG)
White et al. Studies on Adrenocorticotropin. XIII. The Isolation of Two Highly Active Bovine Types
Li et al. Biotransformation of Licochalcone A by transgenic crown galls of Panax quinquefolium

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties